These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8339220)

  • 1. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features.
    Nakano E; Kondoh M; Okatani K; Seguchi T; Sugao H
    Cancer; 1993 Aug; 72(4):1319-23. PubMed ID: 8339220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and progression of renal cell carcinomas as revealed by DNA cytofluorometry and the significance of the presence of polyploid cells.
    Kushima M; Kushima R; Hattori T; Tomoyoshi T
    Urol Res; 1995; 23(6):381-6. PubMed ID: 8788276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of DNA ploidy, cell cycle and cytomorphometry in sarcomatoid renal cell carcinoma.
    Yu DS; Wang J; Chang SY; Ma CP
    Eur Urol; 1991; 20(3):227-31. PubMed ID: 1823046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric nuclear DNA content analysis of renal tumors in children: prognostic significance of nuclear DNA ploidy.
    Li P; Yokomori K; Tsuchida Y; Fujita M; Shimizu K; Tanaka E; Pianovski MA; Takemura T
    Tumour Biol; 1995; 16(6):385-93. PubMed ID: 7569685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
    Currin SM; Lee SE; Walther PJ
    J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
    Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
    Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
    Ljungberg B; Larsson P; Stenling R; Roos G
    J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor heterogeneity of renal cell carcinoma as analyzed by flow cytometry].
    Nagamori S
    Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):593-600. PubMed ID: 2374332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo aneuploidization during the expansion of renal adenocarcinoma.
    Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
    Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content in renal cell carcinoma with reference to tumor heterogeneity.
    Ljungberg B; Stenling R; Roos G
    Cancer; 1985 Aug; 56(3):503-8. PubMed ID: 4005812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
    Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
    J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric analysis of renal cell carcinoma].
    Lü GH
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M; Lipponen P; Nordling S
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
    Yokogi H
    Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.